Navigation Links
Molecular aberration signals cancer
Date:2/19/2014

Several scientists, including one at Simon Fraser University, have made a discovery that strongly links a little understood molecule, which is similar to DNA, to cancer and cancer survival.

EMBO Reports, a life sciences journal published by the European Molecular Biology Organization, has just published online the scientists' findings about small non-coding RNAs.

While RNA is known to be key to our cells' successful creation of proteins, the role of small non-coding RNAs, a newly discovered cousin of the former, has eluded scientific understanding for the most part. Until now, it was only surmised that most of these molecules had nothing to do with protein production.

However, scientists at SFU, the University of British Columbia and the B.C. Cancer Agency have discovered that many non-coding RNAs are perturbed in cancerous human cells, including breast and lung, in a specific way. The disturbance, which manifests itself as shorter than normal molecular messaging, also occurs at a specific spot on genes.

"These two identifiable characteristics give cancer-causing non-coding RNAs a chemical signature that makes it easy for scientists to identify them in the early stages of many different types of cancer," says Steven Jones.

The SFU molecular biology and biochemistry professor is this study's senior author, and the associate director and head of bioinformatics at the B.C. Cancer Agency's Genome Sciences Centre.

"These molecules' existence can also be used to classify cancer patients into subgroups of individuals with different survival outcomes," adds Jones. "While the precise reason why a tumour would change the behaviour of genes in this way is not known, it is likely that it represents a mechanism by which the cancer can subvert and takeover the normally well controlled activity of our genes."

This study uncovered non-coding RNAs' cancerous role by using high-throughput sequencing techniques to analyse reams of genetic information on normal and diseased tissue as part of the Cancer Genome Atlas project.

The Cancer Genome Atlas is an ambitious project to characterize the genetic material of more than 500 tumours from more than 20 different cancers. The project provides a goldmine of data for bioinformaticians such as Jones.


'/>"/>

Contact: Carol Thorbes
cthorbes@sfu.ca
778-782-3035
Simon Fraser University
Source:Eurekalert

Related medicine news :

1. Study uncovers molecular keys to invasive bladder cancer
2. Short circuit in molecular switch intensifies pain
3. Molecular nano-spies to make light work of disease detection
4. Research shows molecular, protein targeting therapies may be best treatment for certain lung cancer
5. Molecular Diagnostics Role in Cancer Testing Analyzed in In-demand TriMark Report Published at MarketPublishers.com
6. New molecular targets identified in some hard-to-treat melanomas provide potential treatment option
7. The Association for Molecular Pathology releases position statement on LDTs
8. Polymer coatings based on molecular structures
9. Supercomputers help ORNL researchers identify key molecular switch that controls cell behavior
10. Mayo Clinic: Drug induces morphologic, molecular and clinical remissions in myelofibrosis
11. Maryville, Tennessee based Molecular Pathology Laboratory Network, Inc. (MPLN) Acquires the First FDA Approved High-Throughput DNA Sequencing Analyzer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/11/2019)... ... 11, 2019 , ... A September 2 article on CBS News ... significantly less likely to suffer heart attacks, strokes, kidney failure, and heart disease versus ... weight loss surgery specialists Dr. Feiz and Associates says the study adds further evidence ...
(Date:9/11/2019)... ... September 11, 2019 , ... GRM Information ... AHIMA Health Data and Information Conference in Chicago, Illinois September 14 to 18. ... learn more about GRM’s healthcare information management solutions . , Built around ...
(Date:9/11/2019)... ... September 11, 2019 , ... PatientPay, the ... healthcare, announces the issuance of a patent to reduce the level of effort ... both time-of-service and post visit patient statements. , At the core of “Instant ...
(Date:9/11/2019)... ROYAL OAK, Mich. (PRWEB) , ... September 10, 2019 , ... ... location. The new office is location at 32686 Woodward Ave, Suite 103, Royal ... 14 mile. , “Our Royal Oak location offers comprehensive women’s health services in a ...
(Date:9/11/2019)... ... September 10, 2019 , ... ... to explore solutions to problems facing the ever-changing corporate landscape, Mediaplanet today ... “Employee Benefits and Engagement.” With topics ranging from the importance of candid ...
Breaking Medicine News(10 mins):
(Date:9/14/2019)... ... 13, 2019 , ... Corey Stern , a partner at Levy Konigsberg, ... Archibald over at least 3 decades while employed by Rockefeller University Hospital (“RUH”). ... Court - Southern District of New York, No. 1:19-cv-01403), the first case filed against ...
(Date:9/14/2019)... N.J. (PRWEB) , ... September 14, 2019 , ... ... trial of four plaintiffs living with peritoneal mesothelioma, a jury in Middlesex County ... first consolidated trial of plaintiffs alleging their mesotheliomas were caused by asbestos-containing J&J ...
(Date:9/11/2019)... China (PRWEB) , ... September ... ... Co., Ltd.“Jiuzhou Pharmaceutical, a world leading Active Pharmaceutical Ingredients (API) contract development ... commitment for the purchase of Suzhou Novartis Pharmaceutical Technology Ltd (SNPT), an ...
Breaking Medicine Technology: